Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation

PURPOSE: In this study, a novel arginine, glycine, aspartic acid peptide (RGD)-modified paclitaxel and curcumin co-loaded liposomes were developed to evaluate their antitumor activity in vitro and in vivo. MATERIALS AND METHODS: Co-loaded liposomes were prepared using the solvent evaporation method....

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Kanqiu, Shen, Mingjing, Xu, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927341/
https://www.ncbi.nlm.nih.gov/pubmed/29731631
http://dx.doi.org/10.2147/IJN.S157746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927341/
https://www.ncbi.nlm.nih.gov/pubmed/29731631
http://dx.doi.org/10.2147/IJN.S157746

Ejemplares similares